The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
Mentioned books
Feb 20, 2020 • 30min
Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review
Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?
Feb 13, 2020 • 25min
Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy
What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?
Feb 6, 2020 • 24min
Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call?
We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-held dream of running a call-in show. Dial us at 617-517-6130 and leave a message with any question you'd like us to answer on the podcast, and you may just hear it on air in the coming weeks.
Jan 30, 2020 • 26min
Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"
Jan 23, 2020 • 22min
Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?
Jan 16, 2020 • 23min
Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap
Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?
Jan 9, 2020 • 26min
Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?
Dec 19, 2019 • 25min
Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease
Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?
Dec 12, 2019 • 25min
Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy
Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?
Dec 5, 2019 • 25min
Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep
How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?
